Funding for this research was provided by:
Applied basic research program of Liaoning Provincial Department of science and technology (2022081505)
Article History
Received: 4 April 2022
Accepted: 6 September 2022
First Online: 2 October 2022
Declarations
:
: The study protocol was approved by the Medical Ethics Committee of the Shengjing Affiliated Hospital of China Medical University (Ethics No. 2021PS248J) and all patients signed informed consent forms. It complies with the statements of the Declaration of Helsinki. It has also been retrospectively registered at Chinese Clinical Trial Registry (ChiCTR) with the registration number: ChiCTR2200058270. Registered 04/04/2022.
: Not applicable.
: The authors declare that they have no competing interests.